During the past decade, Hospital Sao Vicente de Paulo conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 23 clinical trials were completed, i.e. on average, 52.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 19 clinical trials were completed. i.e. 146.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Sao Vicente de Paulo" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Hospital Israelita Albert Einstein" with 5 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Takeda" with 4 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Sao Vicente de Paulo" #1 collaborator was "Brazilian Research In Intensive Care Network" with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Hospital Sirio-Libanes" with 3 trials as a collaborator, "Hospital do Coracao" with 3 trials as a collaborator and "Ministry of Health, Brazil" with 3 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Sao Vicente de Paulo" are "COVID-19" (5 trials), "Multiple Myeloma" (3 trials), "Atrial Fibrillation" (2 trials), "Autism Spectrum Disorder (ASD)" (2 trials) and "COVID-19 Pneumonia" (2 trials). Many other conditions were trialed in "Hospital Sao Vicente de Paulo" in a lesser frequency.

Most popular intervention types in "Hospital Sao Vicente de Paulo" are "Drug" (40 trials), "Other" (7 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Atezolizumab" (2 trials), "Carboplatin" (2 trials), "Empagliflozin" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Sao Vicente de Paulo" are 50 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Sao Vicente de Paulo". 1 are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Hospital Sao Vicente de Paulo, 3 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Sao Vicente de Paulo, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".